Kenneth Jeff Thrasher

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sul...
- Patent number 9,776,992
- Issue date Oct 3, 2017
- Eli Lilly and Company
- Harold Burns Brooks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, methods and formulations for the oral delivery of a gluc...
- Patent number 8,765,796
- Issue date Jul 1, 2014
- Emisphere Technologies, Inc.
- Robert J. Herr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, methods and formulations for the oral delivery of a gluc...
- Patent number 8,552,039
- Issue date Oct 8, 2013
- Emisphere Technologies, Inc.
- Robert Jason Herr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, methods and formulations for the oral delivery of a gluc...
- Patent number 8,546,581
- Issue date Oct 1, 2013
- Emisphere Technologies, Inc.
- Louis Nickolaus Jungheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, methods and formulations for the oral delivery of a gluc...
- Patent number 7,947,841
- Issue date May 24, 2011
- Emisphere Technologies, Inc.
- Louis Nickolaus Jungheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, methods and formulations for the oral delivery of a gluc...
- Patent number 7,662,771
- Issue date Feb 16, 2010
- Emisphere Technologies, Inc.
- Robert Jason Herr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted dipeptides as growth hormone secretagogues
- Patent number 7,125,840
- Issue date Oct 24, 2006
- Eli Lilly and Company
- Jeffrey Alan Dodge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and pharmaceutical compositions for inhibiting MRP1
- Patent number 7,101,891
- Issue date Sep 5, 2006
- Eli Lilly and Company
- Jeffrey Daniel Cohen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for inhibiting MRP1
- Patent number 7,037,921
- Issue date May 2, 2006
- Eli Lilly and Company
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Growth hormone secretagogues
- Patent number 6,992,097
- Issue date Jan 31, 2006
- Eli Lilly and Company
- Kenneth Lee Hauser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compounds for inhibiting MRP1
- Patent number 6,743,794
- Issue date Jun 1, 2004
- Eli Lilly and Company
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective β3 adrenergic agonists
- Patent number 6,686,372
- Issue date Feb 3, 2004
- Eli Lilly and Company
- Thomas A. Crowell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Growth hormone secretagogues
- Patent number 6,639,076
- Issue date Oct 28, 2003
- Eli Lilly and Company
- Kenneth Lee Hauser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acrylic and propionic acid compounds, intermediates, processes, com...
- Patent number 6,440,958
- Issue date Aug 27, 2002
- Eli Lilly and Company
- Charles David Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective β3 adrenergic agonists
- Patent number 6,413,991
- Issue date Jul 2, 2002
- Eli Lilly and Company
- Thomas A. Crowell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acrylic and propionic acid compounds, intermediates, processes, com...
- Patent number 6,350,884
- Issue date Feb 26, 2002
- Eli Lilly and Company
- Charles David Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antithrombotic diamines
- Patent number 6,265,575
- Issue date Jul 24, 2001
- Eli Lilly and Company
- Kenneth Jeff Thrasher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations and applications thereof for the treatm...
- Patent number 6,258,826
- Issue date Jul 10, 2001
- Eli Lilly and Company
- George Joseph Cullinan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carbazolyl-substituted ethanolamines as selective .beta.-.sub.3 ago...
- Patent number 6,140,352
- Issue date Oct 31, 2000
- Eli Lilly and Company
- Thomas A. Crowell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations and applications thereof for the treatm...
- Patent number 6,087,378
- Issue date Jul 11, 2000
- Eli Lilly and Company
- George Joseph Cullinan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzothiophene compounds, intermediates, processes, compositions, a...
- Patent number 6,075,151
- Issue date Jun 13, 2000
- Eli Lilly and Company
- Kenneth Lee Hauser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzothiophene compounds, intermediates, compositions, and methods
- Patent number 5,986,109
- Issue date Nov 16, 1999
- Eli Lilly and Company
- Alan David Palkowitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzothiophene compounds, intermediates, compositions, and methods
- Patent number 5,981,765
- Issue date Nov 9, 1999
- Eli Lilly and Company
- Alan David Palkowitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzothiophene compounds, intermediates, compositions and methods
- Patent number 5,969,142
- Issue date Oct 19, 1999
- Eli Lilly and Company
- Alan David Palkowitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzothiophene compounds, intermediates, compositions, and methods
- Patent number 5,856,339
- Issue date Jan 5, 1999
- Eli Lilly and Company
- Alan David Palkowitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzothiophene compounds, intermediates, processes, compositions, a...
- Patent number 5,843,963
- Issue date Dec 1, 1998
- Eli Lilly and Company
- Kenneth Lee Hauser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 2-substituted benzo �B! Thiophene compounds a...
- Patent number 5,712,390
- Issue date Jan 27, 1998
- Eli Lilly and Company
- Kenneth L. Hauser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 2-substituted benzo�B!thiophene compounds and...
- Patent number 5,710,285
- Issue date Jan 20, 1998
- Eli Lilly and Company
- Kenneth L. Hauser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 2-substituted benzo[b]thiophene compounds and...
- Patent number 5,614,639
- Issue date Mar 25, 1997
- Eli Lilly and Company
- Kenneth L. Hauser
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SUL...
- Publication number 20170233378
- Publication date Aug 17, 2017
- Eli Lilly and Company
- Harold Burns BROOKS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUC...
- Publication number 20140031287
- Publication date Jan 30, 2014
- Emisphere Technologies, Inc.
- Robert Jason Herr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds, Methods and Formulations for the Oral Delivery of a Gluc...
- Publication number 20110190205
- Publication date Aug 4, 2011
- EMISPHERE TECHNOLOGIES, INC.
- Louis Nickolaus Jungheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUC...
- Publication number 20100120876
- Publication date May 13, 2010
- EMISPHERE TECHNOLOGIES, INC.
- Robert Jason Herr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds, Methods and Formulations for the Oral Delivery of a Gluc...
- Publication number 20090239798
- Publication date Sep 24, 2009
- EMISPHERE TECHNOLOGIES, INC.
- Louis Nickolaus Jungheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds, Methods and Formulations for the Oral Delivery of a Gluc...
- Publication number 20080214448
- Publication date Sep 4, 2008
- EMISPHERE TECHNOLOGIES INC.
- Robert Jason Herr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds, Methods and Formulations for the Oral Delivery of a Gluc...
- Publication number 20070293423
- Publication date Dec 20, 2007
- Eli Lilly and Company
- Louis Nickolaus Jungheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Growth Hormone secretagogues
- Publication number 20040122234
- Publication date Jun 24, 2004
- Kenneth Lee Hauser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and pharmaceutical compositions for inhibiting mrp1
- Publication number 20040116460
- Publication date Jun 17, 2004
- Jeffrey Daniel Cohen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds and methods for inhibiting mrp1
- Publication number 20040097507
- Publication date May 20, 2004
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted dipeptides as growth hormone secretagogues
- Publication number 20040058971
- Publication date Mar 25, 2004
- Jeffrey Alan Dodge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and compounds for inhibiting mrp1
- Publication number 20030100576
- Publication date May 29, 2003
- Rosanne Bonjouklian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective B3 adrenergic agonists
- Publication number 20020165234
- Publication date Nov 7, 2002
- Thomas A. Crowell
- C07 - ORGANIC CHEMISTRY

Kenneth Jeff Thrasher

Person

Patents Grantslast 30 patents

1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sul...

Compounds, methods and formulations for the oral delivery of a gluc...

Compounds, methods and formulations for the oral delivery of a gluc...

Compounds, methods and formulations for the oral delivery of a gluc...

Compounds, methods and formulations for the oral delivery of a gluc...

Compounds, methods and formulations for the oral delivery of a gluc...

Substituted dipeptides as growth hormone secretagogues

Compounds and pharmaceutical compositions for inhibiting MRP1

Compounds and methods for inhibiting MRP1

Growth hormone secretagogues

Methods and compounds for inhibiting MRP1

Selective &#x03B2;3 adrenergic agonists

Growth hormone secretagogues

Acrylic and propionic acid compounds, intermediates, processes, com...

Selective &#x03B2;3 adrenergic agonists

Acrylic and propionic acid compounds, intermediates, processes, com...

Antithrombotic diamines

Pharmaceutical formulations and applications thereof for the treatm...

Carbazolyl-substituted ethanolamines as selective .beta.-.sub.3 ago...

Pharmaceutical formulations and applications thereof for the treatm...

Benzothiophene compounds, intermediates, processes, compositions, a...

Benzothiophene compounds, intermediates, compositions, and methods

Benzothiophene compounds, intermediates, compositions, and methods

Benzothiophene compounds, intermediates, compositions and methods

Benzothiophene compounds, intermediates, compositions, and methods

Benzothiophene compounds, intermediates, processes, compositions, a...

Process for preparing 2-substituted benzo �B! Thiophene compounds a...

Process for preparing 2-substituted benzo�B!thiophene compounds and...

Process for preparing 2-substituted benzo[b]thiophene compounds and...

Patents Applicationslast 30 patents

1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SUL...

COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUC...

Compounds, Methods and Formulations for the Oral Delivery of a Gluc...

COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUC...

Compounds, Methods and Formulations for the Oral Delivery of a Gluc...

Compounds, Methods and Formulations for the Oral Delivery of a Gluc...

Compounds, Methods and Formulations for the Oral Delivery of a Gluc...

Growth Hormone secretagogues

Compounds and pharmaceutical compositions for inhibiting mrp1

Compounds and methods for inhibiting mrp1

Substituted dipeptides as growth hormone secretagogues

Methods and compounds for inhibiting mrp1

Selective B3 adrenergic agonists

Selective β3 adrenergic agonists

Selective β3 adrenergic agonists